Cyclerion therapeutics, inc. (CYCN)
CashFlow / Yearly
Dec'19Dec'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-123,008

-115,252

Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation and amortization

2,700

1,528

Gain on disposal of property and equipment

-751

-

Share-based compensation expense

19,631

12,433

Changes in operating assets and liabilities:
Related party accounts receivable

1,474

-

Prepaid expenses

1,099

-384

Other current assets

115

4

Operating lease assets

-3,129

-

Other assets

515

-55

Accounts payable

-331

979

Related party accounts payable

81

-

Accrued research and development costs

-3,064

356

Operating lease liabilities

2,655

-

Accrued expenses and other current liabilities

-1,556

2,018

Net cash (used in) operating activities

-102,215

-97,503

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment

6,888

3,438

Proceeds from sale of property and equipment

173

-

Net cash (used in) investing activities

-6,715

-3,438

CASH FLOWS FROM FINANCING ACTIVITIES:
Gross proceeds from private placement

175,000

-

Costs associated with private placement

10,378

-

Proceeds from exercises of stock options and ESPP

510

-

Transfers from Ironwood

46,439

100,941

Net cash provided by financing activities

211,571

100,941

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-20

-

Net decrease in cash, cash equivalents and restricted cash

102,621

-

Non-cash investing activities
Fixed asset purchases in accounts payable and accrued expenses

823

455